BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18453577)

  • 1. Stabilized beta-catenin potentiates Fas-mediated T cell apoptosis.
    Huang Z; Wang R; Xie H; Shang W; Manicassamy S; Sun Z
    J Immunol; 2008 May; 180(10):6586-92. PubMed ID: 18453577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilized
    Xu X; Huang J; Zhao M; Chen H; Mo J; Zhou X; Su Q; Yu B; Huang Z
    J Immunol Res; 2017; 2017():3469108. PubMed ID: 29250557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis.
    Manicassamy S; Sun Z
    J Immunol; 2007 Jan; 178(1):312-9. PubMed ID: 17182568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin.
    Li Y; Shively JE
    Exp Cell Res; 2013 May; 319(8):1061-72. PubMed ID: 23499736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis.
    Miethke T; Vabulas R; Bittlingmaier R; Heeg K; Wagner H
    Eur J Immunol; 1996 Jul; 26(7):1459-67. PubMed ID: 8766547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
    Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
    Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice.
    Suzuki H; Hayakawa A; Bouchard D; Nakashima I; Mak TW
    Int Immunol; 1997 Sep; 9(9):1367-74. PubMed ID: 9310840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
    Tóth R; Szegezdi E; Molnár G; Lord JM; Fésüs L; Szondy Z
    Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
    Giese T; Davidson WF
    Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells.
    Camacho IA; Nagarkatti M; Nagarkatti PS
    Arch Toxicol; 2002 Oct; 76(10):570-80. PubMed ID: 12373453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma.
    Zhang Y; Xu G; Zhang L; Roberts AI; Shi Y
    J Immunol; 2008 Jul; 181(1):190-6. PubMed ID: 18566384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells.
    Sillett HK; Cruickshank SM; Southgate J; Trejdosiewicz LK
    Immunology; 2001 Mar; 102(3):310-6. PubMed ID: 11298829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
    Zhang J; Gao JX; Salojin K; Shao Q; Grattan M; Meagher C; Laird DW; Delovitch TL
    J Exp Med; 2000 Mar; 191(6):1017-30. PubMed ID: 10727463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.